Presently, treatment of T2DM is indirect and piecemeal, with use of metformin, insulin secretagogues and glucosurics to diminish hyperglycemia; and various agents to treat MetS features of hyperlipidemia and hypertension. The gene discussed is INS; the disease is Hyperglycemia.